TB people Global’s Post

Ending TB Together: Key Learnings from the Media Roundtable on Shorter Regimens I recently attended a media roundtable on shorter regimens for tuberculosis (TB) treatment, co-organized by PLAN Health Advocacy and Development Foundation, Civil Society for the Eradication of Tuberculosis in Nigeria (Oyo State Chapter), and TB People. Here are some key takeaways: * *Shorter Regimens Offer Hope:*Mr. Obatunde Oladapo, Executive Director of PLAN Foundation, emphasized the importance of shorter regimens in improving treatment adherence and completion rates. This reduces the burden on patients and increases the chance of successful treatment. * *Media as Partners in Ending Stigma:* Mr. Oladapo also highlighted the media's crucial role in educating the public and combating the stigma associated with TB. Accurate information is essential in our collective fight against this debilitating disease. * Adams Ademola Temitope, a TB survivor and National Coordinator of TB People in Nigeria, shared her experience of the positive impact shorter regimens have had on treatment ease. She outlined the different durations for various TB treatment types: **Tuberculosis Preventive Therapy (TPT):* 1 month * Drug Resistant Tuberculosis (DRT):* 4 months *Multidrug-resistant TB (MDR-TB):*6 months * **Symptoms and Treatment:** The post listed common TB symptoms (fever, weight loss, night sweats, persistent cough) and emphasized the importance of: * Consistent medication adherence for those infected * Early diagnosis by getting checked at hospitals if symptoms arise * Confidentiality and non-stigmatization by healthcare workers and individuals Together, through education, collaboration, and access to treatment, we can end TB. Let's #EndTB stigma and ensure everyone has access to the care they need. #yeswecanendTB #worldTBday2024 #yestoshorterregimen

“United Nations 🇺🇳 General Assembly- High Level Meeting on Antimicrobial Resistance AMR” It is amusing to note the rate at which countries across the globe have intensified conversations encircling addressing Antimicrobial Resistance (AMR) as a matter of Public Health urgency, from devising Global to individual National Action Plans to Holding webinar series, conferences and regional/global AMR summits. This unprecedentedly underscores the Global commitment on AMR agenda and acknowledging the urgent need to addressing it as a matter of Public Health concern. Today Global Leaders convened in New York for the United Nations High Level Meeting on AMR. (#UNGA_HLM_AMR), Something elating to note as a regional AMR champion and enthusiast. Antimicrobial resistance AMR alone regrettably continues to claim more lives than HIV/AIDS, Tuberculosis (TB)& Malaria combined annually, potentially compromising huge but hardly earned Healthcare milestones, pushing countries to extreme poverty and significantly reduced GDPs especially on the African continent where the situation is dire. #UNGA2024 #UN_HLM_ON_AMR ReAct - Action on Antibiotic Resistance Alliance against Antimicrobial Antipathy -AAA

🌍 Urgent Call for Action: Let’s Eliminate TB! 🌍 The 2024 WHO Global TB Report reveals sobering truths: tuberculosis has reclaimed its position as the leading infectious killer, taking 1.25 million lives in 2023. Progress toward the End TB goals remains alarmingly off-track, and bold, innovative, and comprehensive actions are urgently needed. In our latest commentary, "Insights from the 2024 WHO Global Tuberculosis Report – More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals," we delve into the critical gaps and opportunities to accelerate the fight against TB. This work reflects the collective insights of an extraordinary team: ✨ Delia Goletti – A leading figure in TB research and policy advocacy. ✨ Graeme Meintjes – Champion of TB-HIV research and global health. ✨ Alimuddin Zumla – A global health leader with decades of impactful contributions. ✨ Shui-Shan Lee – A visionary advancing infectious disease control worldwide. We call for: - Strengthened investments in TB research, innovation, and vaccine development. - Scaling up equitable access to diagnostics and treatments, especially in underserved regions. - Integrated approaches to tackle social determinants like poverty, malnutrition, and stigma. Read the full article here (https://lnkd.in/eMQv_sCx) and join us in advocating for a stronger, united front to End TB by 2030. Your thoughts, collaborations, and actions can make a difference. Let’s work together to turn this vision into reality! #EndTB #GlobalHealth #Innovation #Collaboration

TB Stakeholders! Ending tuberculosis (TB) requires a fundamental shift in how all stakeholders think and act, driven by a sense of urgency for improving access and quality in TB prevention and care. Time and quality are of the essence. We must recognize and embrace this urgency within our own ranks and advocate the same throughout our networks, ensuring a coordinated and compelling message. It is unacceptable that access to rapid molecular diagnosis remains below 50%, and that access to TB preventive treatment (TPT) among household contacts is less than 10%. We must urgently utilize the tools and resources currently at our disposal while continuing to push for new innovations, including vaccines. The time to act is now. World Health Organization; Stop TB Partnership; USAID; Unitaid; The Global Fund #EndTB

Despite progress in global health, tuberculosis (TB) remains a persistent challenge, killing someone every 20 seconds. We have been at the forefront, treating and preventing TB in vulnerable communities worldwide including drug-resistant strains. Join us in debunking TB myths and advocating for more accessibility to affordable care: https://lnkd.in/erGBrd-7

PATH's TB REACH Wave 10 project, funded by the Stop TB Partnership, engages with the private sector in Myanmar to integrate tuberculosis (TB) services, increase TB notifications, improve treatment outcomes, and ensure high-quality care aligned with international standards. Focusing on integrating #personcentered #TB services into #PrimaryHealthCare, the project makes it easier for people seeking care to access affordable and diverse services, which aligns with Myanmar’s National Strategic Plan. Engaging private providers, pharmacies, general practitioners, private hospitals, and the National TB Program, the project facilitates linkages between diagnosis and treatment of TB and care for other related diseases.     #WorldTBDay #WeCanEndTB     https://lnkd.in/gyCXZA_3 

In my column for the Gulf News, I write about the pressing issue of tuberculosis (TB). The global TB cases escalated to 10.6 million in 2022, a 6% increase from 2020, attributed to the disruptions caused by the COVID-19 pandemic. TB has been the leading infectious killer over the past decade, with annual deaths surpassing 1.65 million. The disease's impact is notably severe among HIV-positive individuals, particularly in the African region, where TB and HIV coinfection rates are alarmingly high. Furthermore, the battle against drug-resistant TB is far from over, with only 43% of affected patients accessing proper treatment in 2022. The Copenhagen Consensus suggests that with an investment of $6.2 billion annually, significant strides can be made in TB diagnosis and treatment adherence, potentially averting millions of deaths. These figures not only highlight the gravity of the TB crisis but also the critical need for enhanced global efforts in TB management and prevention. #WorldTBDay #TBStatistics #GlobalHealth

Access to health care is crucial to preventing diseases like tuberculosis (TB). In Bangladesh, scientists and nonprofits are joining forces to bring innovative solutions like mobile X-ray machines to communities most likely to have TB. These portable tools help to detect the disease earlier and provide lifesaving care to people who need it most. As researchers and leaders, we need to support efforts like these and advocate for increased access to quality care everywhere. https://lnkd.in/eca4Hq_d 

Big news in global health: Professor Sue Ann Costa Clemens CBE, Chair of Global Health at Oxford University, recently met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss a crucial initiative – the co-development of a Malaria vaccine aimed at improving public health outcomes in Brazil. Brazil has taken the lead in tackling infectious diseases, with malaria being a top priority. In regions like the Amazon, where healthcare access is limited, finding effective solutions is critical. Joined by experts including Professor Teresa Lambe OBE, Professor Simon Draper, and Dr. Angela Minassian, we're diving into the development of a vaccine targeting Vivax Malaria. This could mean a significant breakthrough, particularly for underserved regions, potentially saving countless lives. This partnership highlights our collective efforts against neglected diseases. By combining academic expertise with governmental support, we're driving innovative solutions to alleviate the burden of disease on vulnerable populations worldwide. Ambassador Patriota's visit to Oxford University highlighted the dedication of our teams. Together, we're committed to fostering ongoing collaboration and achieving impactful advancements in global health. Stay tuned for updates on this journey! Read more: https://lnkd.in/eDVBJwHt University of Oxford | Oxford University Department of Paediatrics | Intrials Clinical Research #GlobalHealth #Collaboration #MalariaVaccine #PublicHealthImpact

Very encouraging news about the United States' financial commitment to the Pandemic Fund! This pivotal initiative aims to further enhance global health security and pandemic preparedness worldwide. The U.S. has demonstrated decades of leadership in global health, addressing crucial issues including HIV/AIDS, tuberculosis, malaria, Ebola and COVID-19. It's exciting to see that we are going to continue to lead in protecting our global community from public health threats. #GlobalHealth #PandemicPreparedness #HealthSecurity